Shivalik Rasayan Limited
BSE SHIVALIK.BO
Shivalik Rasayan Limited EBITDA Margin for the year ending March 31, 2024: 15.89%
-
Shivalik Rasayan Limited EBITDA Margin for the year ending March 31, 2023 was 20.35%, a -21.18% change year over year.
-
Shivalik Rasayan Limited EBITDA Margin for the year ending March 31, 2022 was 25.81%, a 23.86% change year over year.
-
Shivalik Rasayan Limited EBITDA Margin for the year ending March 31, 2021 was 20.84%, a 20.81% change year over year.
-
Shivalik Rasayan Limited EBITDA Margin for the year ending March 31, 2020 was 17.25%, a -7.51% change year over year.
| Date | EBITDA Margin | EBIT Margin | Depreciation and Amortization | EBIT |
|---|
| CEO | Dr. Vimal Kumar Shrawat Ph.D. |
| IPO Date | June 24, 2015 |
| Location | India |
| Headquarters | 1506, Chiranjiv Tower |
| Employees | 267 |
| Sector | Industrials |
| Industries | |
Shivalik Rasayan Limited produces and sells chemicals for the protection of plants in India. The company offers Dimethoate technical, which is used in the preparation of formulations for use in the control of various insects and mites; and Malathion technical, an organophosphorus based contact insecticide used in the agricultural production of various food/feed crops. It also manufactures organophosphorus-based insecticides and chemicals. In addition, the company develops and manufactures active pharmaceutical ingredients in oncology, ARVs, cardiovascular, metabolic disorders, and immunology; and manufactures oncology and non-oncology products. Further, the company offers custom manufacturing of chemicals. Shivalik Rasayan Limited was incorporated in 1979 and is based in New Delhi, India. Shivalik Rasayan Limited is a subsidiary of Growel Remedies Limited.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email